James Costello
Concepts (405)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Bladder Neoplasms | 11 | 2023 | 196 | 2.270 |
Why?
| Gene Expression Profiling | 9 | 2023 | 1510 | 1.420 |
Why?
| Algorithms | 13 | 2018 | 1462 | 1.310 |
Why?
| Antineoplastic Agents | 7 | 2020 | 1872 | 1.000 |
Why?
| Computational Biology | 9 | 2018 | 527 | 0.920 |
Why?
| Biomarkers, Tumor | 5 | 2022 | 1029 | 0.920 |
Why?
| Transcriptome | 7 | 2023 | 719 | 0.920 |
Why?
| Gene Regulatory Networks | 6 | 2023 | 229 | 0.900 |
Why?
| Cell Line, Tumor | 18 | 2023 | 2690 | 0.870 |
Why?
| Drug Resistance, Neoplasm | 6 | 2021 | 636 | 0.830 |
Why?
| Neoplasms | 8 | 2020 | 2082 | 0.830 |
Why?
| Prostatic Neoplasms | 4 | 2023 | 911 | 0.810 |
Why?
| Computer Simulation | 5 | 2018 | 858 | 0.780 |
Why?
| Crowdsourcing | 5 | 2023 | 14 | 0.780 |
Why?
| Premature Birth | 2 | 2023 | 274 | 0.760 |
Why?
| Cell-Free Nucleic Acids | 1 | 2021 | 26 | 0.730 |
Why?
| Cisplatin | 2 | 2018 | 261 | 0.680 |
Why?
| Blood Proteins | 1 | 2021 | 217 | 0.650 |
Why?
| Pre-Eclampsia | 1 | 2021 | 165 | 0.640 |
Why?
| Gene Expression Regulation, Neoplastic | 12 | 2023 | 1140 | 0.640 |
Why?
| MutS Homolog 2 Protein | 1 | 2018 | 12 | 0.630 |
Why?
| Chromosomes, Human | 1 | 2018 | 38 | 0.620 |
Why?
| Pharmaceutical Preparations | 1 | 2020 | 163 | 0.610 |
Why?
| Gestational Age | 1 | 2021 | 762 | 0.610 |
Why?
| Whole Genome Sequencing | 1 | 2018 | 93 | 0.600 |
Why?
| Transcription Factors | 4 | 2022 | 1497 | 0.600 |
Why?
| Fluorescence | 1 | 2018 | 148 | 0.590 |
Why?
| CRISPR-Cas Systems | 1 | 2018 | 77 | 0.590 |
Why?
| Models, Biological | 4 | 2018 | 1589 | 0.590 |
Why?
| Tripartite Motif Proteins | 1 | 2017 | 29 | 0.580 |
Why?
| Breast Neoplasms | 5 | 2021 | 1842 | 0.560 |
Why?
| Metabolic Networks and Pathways | 1 | 2018 | 167 | 0.560 |
Why?
| Genetic Loci | 1 | 2018 | 256 | 0.560 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 1356 | 0.550 |
Why?
| Homeodomain Proteins | 5 | 2023 | 460 | 0.540 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 137 | 0.530 |
Why?
| Genomics | 6 | 2023 | 625 | 0.500 |
Why?
| Telomerase | 4 | 2020 | 203 | 0.480 |
Why?
| Image Processing, Computer-Assisted | 1 | 2018 | 681 | 0.460 |
Why?
| MAP Kinase Kinase Kinases | 3 | 2021 | 67 | 0.450 |
Why?
| DNA-Binding Proteins | 6 | 2022 | 1286 | 0.420 |
Why?
| Competitive Behavior | 1 | 2013 | 36 | 0.420 |
Why?
| Oligonucleotide Array Sequence Analysis | 7 | 2016 | 739 | 0.400 |
Why?
| Receptors, Androgen | 3 | 2021 | 131 | 0.390 |
Why?
| Humans | 55 | 2023 | 113531 | 0.380 |
Why?
| Cooperative Behavior | 2 | 2016 | 376 | 0.380 |
Why?
| Carcinoma, Transitional Cell | 3 | 2017 | 53 | 0.370 |
Why?
| Biomedical Research | 2 | 2016 | 581 | 0.370 |
Why?
| Drosophila | 3 | 2008 | 130 | 0.350 |
Why?
| Rhabdomyosarcoma | 2 | 2022 | 55 | 0.350 |
Why?
| Lung Neoplasms | 3 | 2018 | 2148 | 0.350 |
Why?
| Mutation | 7 | 2023 | 3313 | 0.340 |
Why?
| Carcinoma, Pancreatic Ductal | 2 | 2023 | 209 | 0.340 |
Why?
| Zebrafish Proteins | 2 | 2022 | 241 | 0.330 |
Why?
| Protein Interaction Mapping | 1 | 2009 | 100 | 0.310 |
Why?
| Protein Tyrosine Phosphatases | 2 | 2020 | 143 | 0.300 |
Why?
| Drosophila melanogaster | 1 | 2009 | 182 | 0.290 |
Why?
| Databases, Genetic | 3 | 2018 | 205 | 0.290 |
Why?
| DNA Helicases | 2 | 2021 | 133 | 0.280 |
Why?
| Prostatic Neoplasms, Castration-Resistant | 2 | 2017 | 40 | 0.270 |
Why?
| Triple Negative Breast Neoplasms | 2 | 2019 | 157 | 0.260 |
Why?
| Animals | 27 | 2023 | 31162 | 0.250 |
Why?
| Neoplasm Metastasis | 5 | 2020 | 519 | 0.250 |
Why?
| Pancreatic Neoplasms | 2 | 2023 | 721 | 0.250 |
Why?
| Promoter Regions, Genetic | 6 | 2021 | 1110 | 0.250 |
Why?
| Epigenesis, Genetic | 3 | 2020 | 515 | 0.250 |
Why?
| Oncogene Proteins, Fusion | 3 | 2023 | 178 | 0.240 |
Why?
| Epithelial-Mesenchymal Transition | 3 | 2021 | 166 | 0.240 |
Why?
| Meta-Analysis as Topic | 2 | 2023 | 155 | 0.240 |
Why?
| Proteomics | 3 | 2021 | 808 | 0.220 |
Why?
| Nuclear Proteins | 2 | 2020 | 584 | 0.210 |
Why?
| Datasets as Topic | 1 | 2023 | 98 | 0.210 |
Why?
| Mice | 17 | 2023 | 14679 | 0.210 |
Why?
| Melanoma | 2 | 2023 | 620 | 0.200 |
Why?
| Sarcoma, Ewing | 1 | 2023 | 65 | 0.200 |
Why?
| MDS1 and EVI1 Complex Locus Protein | 1 | 2022 | 6 | 0.200 |
Why?
| Neoplasm Invasiveness | 3 | 2018 | 435 | 0.190 |
Why?
| ROC Curve | 2 | 2021 | 442 | 0.190 |
Why?
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2021 | 5 | 0.190 |
Why?
| Cell Proliferation | 8 | 2021 | 2164 | 0.190 |
Why?
| Muscle Development | 1 | 2022 | 93 | 0.190 |
Why?
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 191 | 0.190 |
Why?
| ADAM10 Protein | 1 | 2021 | 28 | 0.180 |
Why?
| Tumor Microenvironment | 2 | 2020 | 428 | 0.180 |
Why?
| Asymptomatic Diseases | 1 | 2021 | 75 | 0.180 |
Why?
| Receptors, CCR2 | 1 | 2020 | 28 | 0.180 |
Why?
| Radiosurgery | 1 | 2023 | 298 | 0.180 |
Why?
| Gamma Rays | 1 | 2021 | 46 | 0.180 |
Why?
| Carcinoma, Lobular | 1 | 2021 | 44 | 0.180 |
Why?
| Neoplasm Recurrence, Local | 3 | 2023 | 848 | 0.180 |
Why?
| Gene Ontology | 1 | 2020 | 46 | 0.180 |
Why?
| PAX3 Transcription Factor | 1 | 2020 | 11 | 0.180 |
Why?
| Proto-Oncogene Protein c-ets-1 | 1 | 2020 | 18 | 0.180 |
Why?
| Forkhead Box Protein O1 | 1 | 2020 | 14 | 0.180 |
Why?
| Wnt Signaling Pathway | 1 | 2022 | 145 | 0.180 |
Why?
| Cytoreduction Surgical Procedures | 1 | 2020 | 39 | 0.170 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 2021 | 72 | 0.170 |
Why?
| CD8-Positive T-Lymphocytes | 3 | 2020 | 686 | 0.170 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 57 | 0.170 |
Why?
| Radiation Injuries | 1 | 2021 | 127 | 0.170 |
Why?
| Chromosomes, Human, Pair 21 | 1 | 2019 | 31 | 0.170 |
Why?
| Cell Differentiation | 3 | 2022 | 1681 | 0.170 |
Why?
| Receptors, Interferon | 1 | 2019 | 47 | 0.160 |
Why?
| Homologous Recombination | 1 | 2019 | 19 | 0.160 |
Why?
| Small Molecule Libraries | 1 | 2020 | 79 | 0.160 |
Why?
| Prognosis | 7 | 2021 | 3318 | 0.160 |
Why?
| Chemotherapy, Adjuvant | 1 | 2020 | 332 | 0.160 |
Why?
| Female | 19 | 2023 | 59115 | 0.160 |
Why?
| Discoidin Domain Receptor 2 | 1 | 2019 | 1 | 0.160 |
Why?
| RNA Interference | 1 | 2021 | 426 | 0.160 |
Why?
| Trisomy | 1 | 2019 | 68 | 0.160 |
Why?
| Reproducibility of Results | 2 | 2023 | 2752 | 0.160 |
Why?
| Kynurenine | 1 | 2019 | 80 | 0.160 |
Why?
| Machine Learning | 2 | 2022 | 316 | 0.160 |
Why?
| Dasatinib | 1 | 2019 | 43 | 0.160 |
Why?
| Microbiota | 2 | 2023 | 646 | 0.160 |
Why?
| Fibrosis | 1 | 2021 | 452 | 0.150 |
Why?
| Neoadjuvant Therapy | 1 | 2020 | 305 | 0.150 |
Why?
| SOXB1 Transcription Factors | 1 | 2019 | 52 | 0.150 |
Why?
| Neoplasm Proteins | 2 | 2018 | 381 | 0.150 |
Why?
| Receptors, Estrogen | 1 | 2021 | 371 | 0.150 |
Why?
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 173 | 0.150 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 367 | 0.150 |
Why?
| Chloroquine | 1 | 2018 | 51 | 0.150 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 112 | 0.150 |
Why?
| Molecular Conformation | 1 | 2018 | 132 | 0.150 |
Why?
| Neoplasms, Experimental | 1 | 2019 | 149 | 0.150 |
Why?
| Macrolides | 1 | 2018 | 56 | 0.150 |
Why?
| Signal Transduction | 6 | 2021 | 4439 | 0.150 |
Why?
| Monte Carlo Method | 1 | 2018 | 136 | 0.150 |
Why?
| Lysosomes | 1 | 2018 | 123 | 0.150 |
Why?
| Histone Code | 1 | 2017 | 28 | 0.140 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 382 | 0.140 |
Why?
| Cell Cycle Proteins | 1 | 2021 | 543 | 0.140 |
Why?
| Down Syndrome | 2 | 2019 | 335 | 0.140 |
Why?
| Adenocarcinoma | 1 | 2023 | 787 | 0.140 |
Why?
| Probability | 1 | 2018 | 285 | 0.140 |
Why?
| Immunity, Cellular | 1 | 2019 | 246 | 0.140 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2019 | 193 | 0.140 |
Why?
| Cell Death | 1 | 2018 | 320 | 0.140 |
Why?
| DNA Damage | 1 | 2019 | 345 | 0.140 |
Why?
| Data Interpretation, Statistical | 2 | 2009 | 315 | 0.140 |
Why?
| Cadherins | 2 | 2015 | 170 | 0.140 |
Why?
| B7-H1 Antigen | 1 | 2018 | 137 | 0.130 |
Why?
| DNA Methylation | 2 | 2017 | 493 | 0.130 |
Why?
| Histidine Kinase | 1 | 2016 | 33 | 0.130 |
Why?
| CD24 Antigen | 1 | 2016 | 20 | 0.130 |
Why?
| Sulfonamides | 1 | 2020 | 442 | 0.130 |
Why?
| Nomograms | 1 | 2016 | 41 | 0.130 |
Why?
| YY1 Transcription Factor | 1 | 2016 | 27 | 0.130 |
Why?
| Transcriptional Activation | 1 | 2018 | 331 | 0.130 |
Why?
| Urologic Neoplasms | 1 | 2016 | 24 | 0.130 |
Why?
| Drug Delivery Systems | 1 | 2019 | 293 | 0.130 |
Why?
| Deoxycytidine | 1 | 2017 | 137 | 0.130 |
Why?
| Organizational Innovation | 2 | 2016 | 132 | 0.130 |
Why?
| Ovarian Neoplasms | 1 | 2020 | 386 | 0.130 |
Why?
| Adenosine Triphosphatases | 1 | 2016 | 152 | 0.130 |
Why?
| Bayes Theorem | 3 | 2023 | 325 | 0.120 |
Why?
| Genetic Heterogeneity | 1 | 2015 | 47 | 0.120 |
Why?
| Neoplastic Stem Cells | 1 | 2019 | 326 | 0.120 |
Why?
| Survival Rate | 4 | 2021 | 1634 | 0.120 |
Why?
| Up-Regulation | 1 | 2018 | 794 | 0.120 |
Why?
| Nerve Tissue Proteins | 1 | 2019 | 521 | 0.120 |
Why?
| Immunotherapy | 1 | 2019 | 472 | 0.120 |
Why?
| rho Guanine Nucleotide Dissociation Inhibitor beta | 1 | 2014 | 4 | 0.120 |
Why?
| Alleles | 1 | 2017 | 781 | 0.120 |
Why?
| Membrane Proteins | 1 | 2021 | 1008 | 0.120 |
Why?
| Telomere Homeostasis | 1 | 2015 | 24 | 0.120 |
Why?
| Transcription, Genetic | 3 | 2017 | 1282 | 0.120 |
Why?
| Longitudinal Studies | 1 | 2021 | 2361 | 0.120 |
Why?
| Phenotype | 2 | 2020 | 2754 | 0.120 |
Why?
| Infant, Newborn | 2 | 2023 | 5032 | 0.120 |
Why?
| Histone Demethylases | 1 | 2014 | 28 | 0.120 |
Why?
| Phylogeny | 3 | 2023 | 783 | 0.120 |
Why?
| Receptors, Antigen, T-Cell | 1 | 2018 | 613 | 0.120 |
Why?
| Ubiquitin Thiolesterase | 1 | 2014 | 35 | 0.120 |
Why?
| rho GTP-Binding Proteins | 1 | 2014 | 59 | 0.120 |
Why?
| Arthritis, Rheumatoid | 1 | 2022 | 996 | 0.110 |
Why?
| Microsatellite Repeats | 1 | 2014 | 132 | 0.110 |
Why?
| Ornithine Decarboxylase Inhibitors | 1 | 2013 | 3 | 0.110 |
Why?
| Drug Synergism | 1 | 2014 | 312 | 0.110 |
Why?
| Anabolic Agents | 1 | 2013 | 11 | 0.110 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2022 | 777 | 0.110 |
Why?
| High-Throughput Screening Assays | 1 | 2015 | 123 | 0.110 |
Why?
| Models, Theoretical | 1 | 2017 | 505 | 0.110 |
Why?
| International Cooperation | 1 | 2014 | 168 | 0.110 |
Why?
| Brain Neoplasms | 1 | 2021 | 964 | 0.110 |
Why?
| Drug Combinations | 1 | 2014 | 285 | 0.110 |
Why?
| Models, Molecular | 1 | 2018 | 1359 | 0.110 |
Why?
| Databases, Protein | 2 | 2014 | 59 | 0.110 |
Why?
| Organ Sparing Treatments | 1 | 2013 | 31 | 0.110 |
Why?
| Epigenomics | 1 | 2014 | 98 | 0.110 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2020 | 533 | 0.110 |
Why?
| Biomarkers | 2 | 2021 | 3389 | 0.110 |
Why?
| Xenograft Model Antitumor Assays | 3 | 2021 | 693 | 0.110 |
Why?
| Pregnancy | 2 | 2023 | 5490 | 0.110 |
Why?
| Models, Statistical | 1 | 2016 | 593 | 0.100 |
Why?
| Software | 2 | 2014 | 525 | 0.100 |
Why?
| Cluster Analysis | 2 | 2016 | 448 | 0.100 |
Why?
| Superoxides | 1 | 2013 | 186 | 0.100 |
Why?
| Prostate | 1 | 2013 | 157 | 0.100 |
Why?
| Apoptosis | 3 | 2021 | 2288 | 0.100 |
Why?
| Cyclin-Dependent Kinase 4 | 1 | 2012 | 33 | 0.100 |
Why?
| Genome-Wide Association Study | 1 | 2018 | 1157 | 0.100 |
Why?
| Integrins | 2 | 2023 | 80 | 0.100 |
Why?
| Community-Institutional Relations | 1 | 2013 | 89 | 0.100 |
Why?
| Tumor Suppressor Proteins | 1 | 2014 | 283 | 0.100 |
Why?
| Mice, Inbred C57BL | 5 | 2021 | 4617 | 0.100 |
Why?
| Alternative Splicing | 1 | 2013 | 184 | 0.100 |
Why?
| B-Lymphocytes | 2 | 2014 | 757 | 0.100 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 227 | 0.090 |
Why?
| Saccharomyces cerevisiae | 3 | 2012 | 475 | 0.090 |
Why?
| Genome, Insect | 2 | 2009 | 20 | 0.090 |
Why?
| Male | 10 | 2023 | 55112 | 0.090 |
Why?
| Reactive Oxygen Species | 1 | 2013 | 516 | 0.090 |
Why?
| Hematopoietic Stem Cells | 1 | 2013 | 337 | 0.090 |
Why?
| MCF-7 Cells | 2 | 2021 | 104 | 0.090 |
Why?
| Genetic Predisposition to Disease | 1 | 2018 | 2077 | 0.090 |
Why?
| Enzyme Inhibitors | 1 | 2013 | 737 | 0.090 |
Why?
| Testosterone | 1 | 2013 | 341 | 0.090 |
Why?
| Inflammation | 1 | 2020 | 2444 | 0.090 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2012 | 283 | 0.090 |
Why?
| Horns | 1 | 2009 | 1 | 0.080 |
Why?
| Expressed Sequence Tags | 1 | 2009 | 38 | 0.080 |
Why?
| Pseudogenes | 1 | 2009 | 18 | 0.080 |
Why?
| Models, Genetic | 2 | 2009 | 542 | 0.080 |
Why?
| Coleoptera | 1 | 2009 | 24 | 0.080 |
Why?
| Drug Discovery | 2 | 2022 | 122 | 0.080 |
Why?
| Systems Integration | 1 | 2009 | 37 | 0.080 |
Why?
| Stem Cells | 1 | 2013 | 538 | 0.080 |
Why?
| Genes, Fungal | 1 | 2009 | 49 | 0.080 |
Why?
| Zebrafish | 2 | 2022 | 407 | 0.080 |
Why?
| Tumor Cells, Cultured | 2 | 2021 | 834 | 0.070 |
Why?
| Genetic Diseases, Inborn | 1 | 2008 | 35 | 0.070 |
Why?
| Mitochondria | 1 | 2013 | 735 | 0.070 |
Why?
| Gene Deletion | 1 | 2009 | 351 | 0.070 |
Why?
| Genes, Insect | 1 | 2007 | 19 | 0.070 |
Why?
| Combined Modality Therapy | 2 | 2020 | 1114 | 0.070 |
Why?
| Genome, Human | 1 | 2009 | 342 | 0.070 |
Why?
| BRCA1 Protein | 2 | 2020 | 56 | 0.070 |
Why?
| Disease | 1 | 2008 | 85 | 0.070 |
Why?
| Genetics, Population | 1 | 2008 | 179 | 0.070 |
Why?
| Oxidative Stress | 1 | 2013 | 1065 | 0.070 |
Why?
| Selection, Genetic | 1 | 2008 | 227 | 0.070 |
Why?
| Prednisone | 2 | 2017 | 229 | 0.070 |
Why?
| Chromatin | 2 | 2022 | 418 | 0.060 |
Why?
| Follow-Up Studies | 3 | 2020 | 4384 | 0.060 |
Why?
| T-Lymphocytes | 1 | 2013 | 1725 | 0.060 |
Why?
| Cell Line | 3 | 2019 | 2581 | 0.060 |
Why?
| Adult | 3 | 2021 | 30245 | 0.060 |
Why?
| Base Sequence | 3 | 2017 | 2080 | 0.060 |
Why?
| Anti-Bacterial Agents | 1 | 2013 | 1465 | 0.060 |
Why?
| Cell Movement | 2 | 2021 | 852 | 0.060 |
Why?
| Evolution, Molecular | 1 | 2007 | 424 | 0.060 |
Why?
| Protein Binding | 2 | 2020 | 1867 | 0.050 |
Why?
| Proto-Oncogene Protein c-fli-1 | 1 | 2023 | 18 | 0.050 |
Why?
| RNA-Binding Protein EWS | 1 | 2023 | 18 | 0.050 |
Why?
| Internet | 1 | 2008 | 590 | 0.050 |
Why?
| BCG Vaccine | 1 | 2023 | 18 | 0.050 |
Why?
| Cells, Cultured | 3 | 2016 | 3802 | 0.050 |
Why?
| Mice, Nude | 2 | 2016 | 625 | 0.050 |
Why?
| Biological Assay | 1 | 2023 | 112 | 0.050 |
Why?
| Proteins | 1 | 2008 | 890 | 0.050 |
Why?
| Vagina | 1 | 2023 | 146 | 0.050 |
Why?
| Myogenin | 1 | 2022 | 12 | 0.050 |
Why?
| MyoD Protein | 1 | 2022 | 26 | 0.050 |
Why?
| Rhabdomyosarcoma, Embryonal | 1 | 2022 | 17 | 0.050 |
Why?
| Adjuvants, Immunologic | 1 | 2023 | 204 | 0.050 |
Why?
| Mice, Knockout | 2 | 2022 | 2523 | 0.050 |
Why?
| Aged | 4 | 2023 | 18944 | 0.050 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2022 | 78 | 0.050 |
Why?
| Cell Lineage | 2 | 2013 | 305 | 0.050 |
Why?
| Chondrogenesis | 1 | 2022 | 77 | 0.050 |
Why?
| Chromatin Assembly and Disassembly | 1 | 2022 | 87 | 0.050 |
Why?
| Phenylthiohydantoin | 1 | 2021 | 40 | 0.050 |
Why?
| Skull | 1 | 2022 | 115 | 0.050 |
Why?
| Wnt Proteins | 1 | 2022 | 124 | 0.050 |
Why?
| Ephrin-B2 | 1 | 2021 | 34 | 0.050 |
Why?
| Neural Crest | 1 | 2022 | 112 | 0.050 |
Why?
| Breast | 1 | 2021 | 138 | 0.040 |
Why?
| Nitriles | 1 | 2021 | 149 | 0.040 |
Why?
| Benzamides | 1 | 2021 | 168 | 0.040 |
Why?
| Cartilage | 1 | 2022 | 178 | 0.040 |
Why?
| Tamoxifen | 1 | 2021 | 190 | 0.040 |
Why?
| beta Catenin | 1 | 2022 | 208 | 0.040 |
Why?
| Melanoma, Experimental | 1 | 2020 | 89 | 0.040 |
Why?
| Quinolinic Acid | 1 | 2019 | 7 | 0.040 |
Why?
| Chromatin Immunoprecipitation | 1 | 2020 | 126 | 0.040 |
Why?
| Biosynthetic Pathways | 1 | 2019 | 19 | 0.040 |
Why?
| Chondrocytes | 1 | 2022 | 198 | 0.040 |
Why?
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 44 | 0.040 |
Why?
| Androgens | 1 | 2021 | 166 | 0.040 |
Why?
| Double-Blind Method | 1 | 2023 | 1643 | 0.040 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 155 | 0.040 |
Why?
| Enhancer Elements, Genetic | 1 | 2020 | 148 | 0.040 |
Why?
| Nanog Homeobox Protein | 1 | 2019 | 11 | 0.040 |
Why?
| Inhibitor of Differentiation Proteins | 1 | 2018 | 2 | 0.040 |
Why?
| Cell Cycle | 1 | 2021 | 538 | 0.040 |
Why?
| Mice, SCID | 1 | 2019 | 311 | 0.040 |
Why?
| Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 37 | 0.040 |
Why?
| 5-Methylcytosine | 1 | 2017 | 16 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2020 | 387 | 0.040 |
Why?
| Kaplan-Meier Estimate | 1 | 2020 | 809 | 0.040 |
Why?
| Protein Kinase Inhibitors | 1 | 2023 | 779 | 0.040 |
Why?
| CpG Islands | 1 | 2017 | 118 | 0.040 |
Why?
| Mice, Inbred NOD | 1 | 2019 | 551 | 0.030 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2017 | 58 | 0.030 |
Why?
| Co-Repressor Proteins | 1 | 2016 | 13 | 0.030 |
Why?
| Taxoids | 1 | 2016 | 93 | 0.030 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2016 | 39 | 0.030 |
Why?
| Logistic Models | 1 | 2021 | 1832 | 0.030 |
Why?
| Mice, Inbred BALB C | 1 | 2019 | 1136 | 0.030 |
Why?
| Chromosome Deletion | 1 | 2016 | 94 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2016 | 150 | 0.030 |
Why?
| Heterografts | 1 | 2016 | 117 | 0.030 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 239 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2016 | 1856 | 0.030 |
Why?
| DNA Copy Number Variations | 1 | 2016 | 153 | 0.030 |
Why?
| Protein Domains | 1 | 2016 | 207 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2016 | 298 | 0.030 |
Why?
| Sequence Analysis, DNA | 2 | 2008 | 716 | 0.030 |
Why?
| Interdisciplinary Communication | 1 | 2016 | 183 | 0.030 |
Why?
| Chromosome Mapping | 1 | 2016 | 476 | 0.030 |
Why?
| Exome | 1 | 2016 | 200 | 0.030 |
Why?
| rhoC GTP-Binding Protein | 1 | 2014 | 5 | 0.030 |
Why?
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 5 | 0.030 |
Why?
| Metabolomics | 1 | 2019 | 508 | 0.030 |
Why?
| Urothelium | 1 | 2015 | 33 | 0.030 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2020 | 960 | 0.030 |
Why?
| Survival Analysis | 1 | 2017 | 1203 | 0.030 |
Why?
| rac1 GTP-Binding Protein | 1 | 2014 | 53 | 0.030 |
Why?
| Gene Expression | 1 | 2019 | 1397 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2023 | 2293 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 2009 | 2741 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2014 | 227 | 0.030 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 324 | 0.030 |
Why?
| Neoplasm Grading | 1 | 2015 | 241 | 0.030 |
Why?
| Sequence Analysis, Protein | 1 | 2014 | 27 | 0.030 |
Why?
| Intrinsically Disordered Proteins | 1 | 2014 | 15 | 0.030 |
Why?
| Eflornithine | 1 | 2013 | 3 | 0.030 |
Why?
| Point Mutation | 1 | 2015 | 214 | 0.030 |
Why?
| Ornithine Decarboxylase | 1 | 2013 | 8 | 0.030 |
Why?
| Follistatin | 1 | 2013 | 12 | 0.030 |
Why?
| Protein Conformation | 1 | 2016 | 798 | 0.030 |
Why?
| Amino Acid Motifs | 1 | 2014 | 196 | 0.030 |
Why?
| Blotting, Western | 1 | 2016 | 1128 | 0.030 |
Why?
| Aminoglycosides | 1 | 2013 | 13 | 0.030 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2016 | 357 | 0.030 |
Why?
| Databases, Factual | 1 | 2018 | 1127 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 2016 | 984 | 0.030 |
Why?
| Treatment Outcome | 2 | 2017 | 9006 | 0.030 |
Why?
| Area Under Curve | 1 | 2014 | 271 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 435 | 0.030 |
Why?
| Clinical Trials as Topic | 1 | 2017 | 922 | 0.030 |
Why?
| Neoplasm Staging | 1 | 2016 | 1159 | 0.030 |
Why?
| beta-Lactams | 1 | 2013 | 27 | 0.030 |
Why?
| Enzyme Activation | 1 | 2015 | 752 | 0.030 |
Why?
| Organ Size | 1 | 2013 | 420 | 0.030 |
Why?
| Doxycycline | 1 | 2012 | 53 | 0.030 |
Why?
| Genes, ras | 1 | 2012 | 91 | 0.030 |
Why?
| Bone Marrow Transplantation | 1 | 2013 | 234 | 0.020 |
Why?
| Cell Cycle Checkpoints | 1 | 2012 | 85 | 0.020 |
Why?
| Antigens, CD | 1 | 2014 | 437 | 0.020 |
Why?
| Cytokines | 1 | 2019 | 1795 | 0.020 |
Why?
| Young Adult | 2 | 2017 | 10400 | 0.020 |
Why?
| Quinolones | 1 | 2013 | 97 | 0.020 |
Why?
| Middle Aged | 3 | 2017 | 26552 | 0.020 |
Why?
| Hydrogen Peroxide | 1 | 2013 | 287 | 0.020 |
Why?
| Linear Models | 1 | 2014 | 767 | 0.020 |
Why?
| Repressor Proteins | 1 | 2014 | 358 | 0.020 |
Why?
| Benzimidazoles | 1 | 2012 | 137 | 0.020 |
Why?
| DNA | 1 | 2017 | 1331 | 0.020 |
Why?
| Adenosine Triphosphate | 1 | 2013 | 426 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2013 | 1214 | 0.020 |
Why?
| Pupa | 1 | 2009 | 10 | 0.020 |
Why?
| Body Weight | 1 | 2013 | 853 | 0.020 |
Why?
| Cell Survival | 1 | 2012 | 1004 | 0.020 |
Why?
| Gene Library | 1 | 2009 | 113 | 0.020 |
Why?
| Adolescent | 2 | 2017 | 17724 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2013 | 1604 | 0.020 |
Why?
| Larva | 1 | 2009 | 189 | 0.020 |
Why?
| Staphylococcus aureus | 1 | 2012 | 381 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2013 | 1925 | 0.020 |
Why?
| Escherichia coli | 1 | 2012 | 712 | 0.020 |
Why?
| Disease Progression | 1 | 2015 | 2364 | 0.020 |
Why?
| Risk Factors | 1 | 2021 | 8606 | 0.020 |
Why?
| Synteny | 1 | 2007 | 16 | 0.020 |
Why?
| Gene Order | 1 | 2007 | 24 | 0.020 |
Why?
| RNA, Messenger | 1 | 2015 | 2507 | 0.020 |
Why?
| Genome, Mitochondrial | 1 | 2007 | 27 | 0.020 |
Why?
| Time Factors | 1 | 2017 | 6032 | 0.020 |
Why?
| Codon | 1 | 2007 | 84 | 0.020 |
Why?
| DNA Transposable Elements | 1 | 2007 | 97 | 0.020 |
Why?
| Sequence Alignment | 1 | 2007 | 321 | 0.020 |
Why?
| Immunity | 1 | 2007 | 120 | 0.020 |
Why?
| Multigene Family | 1 | 2007 | 187 | 0.020 |
Why?
| Terminology as Topic | 1 | 2008 | 185 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2017 | 6296 | 0.020 |
Why?
| RNA, Untranslated | 1 | 2007 | 112 | 0.020 |
Why?
| Reproduction | 1 | 2007 | 174 | 0.020 |
Why?
| Drosophila Proteins | 1 | 2007 | 159 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2013 | 1417 | 0.010 |
Why?
| Child | 1 | 2023 | 18340 | 0.010 |
Why?
| RNA | 1 | 2008 | 801 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2008 | 3470 | 0.010 |
Why?
|
|
Costello's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|